Skip to main content

BIOLARGO INC

For the period ended Dec 31, 2023. Filed Apr 1, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 1, 2024

BLGOStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I.
Item 1.Business1
Item 1A.Risk Factors9
Item 1B.Unresolved Staff Comments20
Item 1C.Cybersecurity20
Item 2.Properties20
Item 3.Legal Proceedings20
Item 4.Mine Safety Disclosures20
PART II.
Item 5.Market for Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities21
Item 6.Selected Financial Data22
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations22
Item 7A.Quantitative and Qualitative Disclosures About Market Risk29
Item 8.Financial Statements and Supplementary Data29
Item 9.Changes In and Disagreements with Accountants on Accounting and Financial Disclosure29
Item 9A.Controls and Procedures30
Item 9B.Other Information31
PART III.
Item 10.Directors, Executive Officers, and Corporate Governance32
Item 11.Executive Compensation32
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters32
Item 13.Certain Relationships and Related Transactions, and Director Independence32
Item 14.Principal Accounting Fees and Services32
PART IV.
Item 15.Exhibits, Financial Statement Schedules33
Signatures37
Index to Financial StatementsF-1
Report of Independent Registered Public Accounting FirmF-2
Consolidated Financial Statements for the Years Ended December 31, 2023 and 2022F-9
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.